|
Volume 271, Number 27,
Issue of July 5, 1996
pp. 15950-15962
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Molecular Determinants of High Affinity Binding of -Scorpion
Toxin and Sea Anemone Toxin in the S3-S4 Extracellular Loop in Domain
IV of the Na+ Channel Subunit*
(Received for publication, February 5, 1996, and in revised form, April 8, 1996)
John C.
Rogers
,
Yusheng
Qu
,
Timothy N.
Tanada
,
Todd
Scheuer
and
William A.
Catterall
From the Department of Pharmacology, University of Washington,
Seattle, Washington 98195
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
-Scorpion toxins and sea anemone toxins bind
to a common extracellular site on the Na+ channel and
inhibit fast inactivation. Basic amino acids of the toxins and domains
I and IV of the Na+ channel subunit have been
previously implicated in toxin binding. To identify acidic residues
required for toxin binding, extracellular acidic amino acids in domains
I and IV of the type IIa Na+ channel subunit were
converted to neutral or basic amino acids using site-directed
mutagenesis, and altered channels were transiently expressed in tsA-201
cells and tested for 125I- -scorpion toxin binding.
Conversion of Glu1613 at the extracellular end of
transmembrane segment IVS3 to Arg or His blocked measurable
-scorpion toxin binding, but did not affect the level of expression
or saxitoxin binding affinity. Conversion of individual residues in the
IVS3-S4 extracellular loop to differently charged residues or to Ala
identified seven additional residues whose mutation caused significant
effects on binding of -scorpion toxin or sea anemone toxin.
Moreover, chimeric Na+ channels in which amino acid
residues at the extracellular end of segment IVS3 of the subunit of
cardiac Na+ channels were substituted into the type IIa
channel sequence had reduced affinity for -scorpion toxin
characteristic of cardiac Na+ channels.
Electrophysiological analysis showed that E1613R has 62- and 82-fold
lower affinities for -scorpion and sea anemone toxins, respectively.
Dissociation of -scorpion toxin is substantially accelerated at all
potentials compared to wild-type channels. -Scorpion toxin binding
to wild type and E1613R had similar voltage dependence, which was
slightly more positive and steeper than the voltage dependence of
steady-state inactivation. These results indicate that nonidentical
amino acids of the IVS3-S4 loop participate in -scorpion toxin and
sea anemone toxin binding to overlapping sites and that neighboring
amino acid residues in the IVS3 segment contribute to the difference in
-scorpion toxin binding affinity between cardiac and neuronal
Na+ channels. The results also support the hypothesis that
this region of the Na+ channel is important for coupling
channel activation to fast inactivation.
INTRODUCTION
Voltage-gated Na+ channels are responsible for the
conduction of electrical impulses in most excitable tissues (1). The
importance of their function is demonstrated by the effects of
Na+ channel-specific neurotoxins that bind to at least six
different receptor sites on the Na+ channel molecule and
disrupt its normal behavior (reviewed in Refs. 2 and 3). These natural
toxins are powerful tools for understanding and correlating ion channel
structure and function, as exemplified by identification of molecular
determinants for binding of the pore blocker tetrodotoxin,
which has provided important information about the structure of
the ion selectivity filter and pore (3, 4). Similarly, the
identification of molecular determinants for binding of toxins that
modify activation or inactivation will likely provide important
information about the mechanisms of channel gating.
Neuronal Na+ channels consist of a 260-kDa subunit with
two auxiliary subunits, 1 and 2 (reviewed in Ref. 3). The subunit is independently functional when expressed in
Xenopus oocytes or mammalian cells, and contains the ion
pore and neurotoxin binding sites 1-3 and 5 (reviewed in Refs. 3 and
4). It contains four homologous domains (I-IV) that surround a central
ion pore, and each domain contains six transmembrane segments (S1-S6)
and a short membrane-penetrating segment (SS1-SS2) between segments S5
and S6. The four short SS1-SS2 segments form the ion selectivity filter
and the tetrodotoxin receptor site, and the S4 transmembrane segments
act as voltage sensors (3, 4). The intracellular loop between domains
III and IV acts as a fast inactivation gate, blocking the conduction
pathway following channel activation (3, 4).
Na+ channel-specific -scorpion toxins and sea anemone
toxins are distinct families of peptide toxins that share no sequence
homology, but slow inactivation by binding to common or overlapping
elements of neurotoxin receptor site 3 on the extracellular surface of
the Na+ channel (reviewed in Ref. 2). The three-dimensional
structures of -scorpion and sea anemone toxins (5, 6, 7, 8, 9), the effects
of peptide-specific antibodies and chemical modification (10, 11, 12, 13, 14), and
site-directed mutagenesis (15, 16) indicate that conserved basic amino
acid residues of these toxins are important for binding to the sodium
channel.
The binding affinity of both of these classes of toxins is decreased by
depolarization (17, 18, 19, 20, 21, 22). The voltage dependence of binding and the
specific effect of these toxins on inactivation (19, 20, 21, 22, 23) imply that
membrane potential affects the structure of neurotoxin receptor site 3, that this region of the channel is important for the coupling of
activation to inactivation, and that toxin binding to this site can
slow or block a conformational change required for fast inactivation.
Photoreactive derivatives of -scorpion toxins covalently label both
and 1 subunits (24, 25, 26), but subunits expressed alone in
Chinese hamster ovary cells retain high affinity binding of
-scorpion toxin (27). Two distinct regions of the Na+
channel subunit have been implicated in -scorpion toxin binding
by photoaffinity labeling of the S5-SS1 loop in domain I and inhibition
of toxin binding by site-directed antipeptide antibodies directed
against peptides of the S5-SS1 and SS2-S6 loops in domain I and the
S5-SS1 loop in domain IV (28, 29).
In this study, extracellular acidic amino acids in domains I and IV of
the Na+ channel were converted to neutral or basic amino
acids, and the resulting mutants were tested for -scorpion toxin
affinity by transient expression in mammalian cells.
Glu1613 in the extracellular loop between segments IVS3 and
IVS4 was identified as a major determinant of
LqTx1 and ATX II binding. Mutation of
additional residues within and adjacent to this loop identified
residues important for either LqTx or ATX II binding, indicating that
unique molecular determinants in this region form overlapping binding
sites for -scorpion toxins and sea anemone toxins and contribute to
differences in binding of -scorpion toxins between cardiac and
neuronal Na+ channels.
EXPERIMENTAL PROCEDURES
Materials
-Scorpion toxin (LqTx) was purified from venom
(Leiurus quinquestriatus quinquestriatus, Latoxan) and
iodinated as described previously (17, 29). Antibiotics,
lactoperoxidase, and poly-D-lysine (70 kDa) were from
Sigma. Na125I and [35S]dATP were from DuPont
NEN, and [3H]saxitoxin was from Amersham. Tetrodotoxin
and sea anemone toxin (Anemonia sulcata toxin II- Ile
variant, ATX II) were from Calbiochem. RPMI and Dulbecco's modified
Eagle's medium/F-12 cell culture media were from Life Technologies,
Inc./BRL. Restriction endonucleases and other molecular biology
reagents were from New England Biolabs and Boehringer Mannheim.
Oligonucleotides were synthesized in the Molecular Pharmacology DNA
Core Facility at the University of Washington. Molecular cloning
vectors and bacterial strains were obtained from the following sources:
pCDM8 vector and JM103, CJ236, and MC1061 Escherichia coli
bacterial strains (Invitrogen), M13mp18/19 (New England Biolabs), and
pEBO-pCD-leu2 (CD8 antigen vector, American Type Culture Collection).
Human embryonic kidney tsA-201 cells, a simian virus 40 (SV40) large
T-antigen expressing derivative of HEK-293 cells, were kindly provided
by Dr. Robert Dubridge (Cell Genesis, Foster City, CA). Anti-CD8
antibody-coated microspheres (Dynabeads M-450 CD8) were from Dynal
(Great Neck, NY).
Cell Culture
CNaIIa-1 cells stably expressing the rIIa
Na+ channel subunit were maintained in RPMI media
supplemented with 5% fetal bovine serum (Hyclone), as described
previously (27). For 125I-LqTx binding, these cells were
plated into 24-well (1.6 cm, Falcon) cell culture plates at a density
of 20,000 cells/cm2, fed every other day until confluent,
then assayed for binding. The tsA-201 cells were maintained in
Dulbecco's modified Eagle's medium/F-12 media supplemented with 10%
fetal bovine serum, 20 µg/ml penicillin, and 10 µg/ml streptomycin.
Both lines were maintained at 37 °C in a 5% CO2
incubator.
Mutagenesis and Assembly of cDNAs Encoding Na+
Channels with Site-directed Mutations
Three M13 constructs
containing type IIa Na+ channel subunit cDNA
sequence (30, 31, 32) were used for mutagenesis: mp18KXNC, which contained
a KpnI/XbaI fragment (nt 23-540); mp19XaI, which
contained a XbaI/SmaI fragment (nt 541-1897);
and, mp18RVNC, which contained an EcoRV fragment (nt
4279-5997). Uracil-containing mutagenesis templates were prepared from
each of these constructs, and oligonucleotide-directed mutagenesis was
performed using the
dut ung selection
procedure (33). Mutations made in the above three M13 mutagenesis
constructs were confirmed by sequencing (Sequenase, U. S. Biochemical
Corp.), excised by restriction cutting at the sites used for subcloning
into the M13 constructs, and isolated by low-melting point agarose gel
electrophoresis and GeneClean. Fragments from mp18KXNC were subcloned
into Kpn/XbaI cut pCDM8SalK-NC, and fragments
from mp19XaI and mp18RVNC were subcloned into appropriately cut and
purified pCDM8Sal-NC. All mutations were then confirmed in the final
constructs by DNA sequencing and extensive restriction mapping.
Approximately one cDNA clone in 20 was found in this way to have
rearranged during bacterial growth and clonal amplification of the
plasmids, probably due to recombination of the related cDNA
sequences encoding the four homologous domains of the Na+
channel. To be certain that undetected rearrangements did not influence
interpretation of our results, multiple independently isolated cDNA
clones were analyzed for each mutant channel which had altered toxin
binding properties.
For transient expression, pCDM8Sal-NC and pCDM8SalK-NC were created by
digesting the rIIa subunit (31, 32) with SalI and
subcloning into two modified pCDM8 transient expression vectors. The
vector pCDM8Sal was created by excision of the pCDM8 polylinker region
with XbaI and addition of a SalI site to the
polylinker, and was then used to make pCDM8SalK by removal of a
KpnI site in pCDM8Sal through KpnI digestion,
filling the single-strand overhang with T4 DNA polymerase, and ligating
using standard protocols.
Construction of cDNAs Encoding Chimeras of Cardiac and Brain
Sodium Channels
The chimeras in the IVS3-S4 segment of the
Na+ channel (see Fig. 5) were constructed by site-directed
mutagenesis as described above. An additional larger cardiac chimera in
which the IVSS2-S6 loop was converted from brain to cardiac sequence
(Table I) required an alternative strategy. The antisense
oligonucleotide
5 -GAAAATCCCCACCGCGGGGTTCCCACAGCCAGCCGGCAGACGTCGTGATTTGG-3
was annealed to rIIa nt 5124-5262 in mp18RVNC to create a
single-stranded loop-out of nt 5149-5234. These nucleotides were then
deleted by loop-out mutagenesis while creating unique AatII
and SacII restriction sites at positions 5137 and 5249 through silent mutations. Rat cardiac RNA was prepared from 14-day rat
heart tissue by homogenization with a Polytron (Brinkman) in acidic
phenol according to the manufacturer's instructions (Trizol, Life
Technologies, Inc./BRL). Complementary DNA was prepared using
Superscript reverse transcriptase (Life Technologies, Inc./BRL). The
forward and reverse cardiac-specific (34) oligonucleotide
primer/adapters 5 -CACGACGTCAGCCGGCTGG-3 and 5 -CCACCGCGGGGCTCCCAC-3 ,
respectively, were used to amplify the analogous loop sequence from rat
heart cDNA with the polymerase chain reaction according to
manufacturer's instructions (AmpliTaq, Perkin Elmer). This product was
purified with GeneClean (BIO-101), digested with AatII and
SacII, and then subcloned into the correct reading frame of
the above mutation. The junctions and the 219 base pairs of inserted
rH1 sequence were then confirmed before subcloning into the full-length
rIIA cDNA as above.
Fig. 5.
Analysis of chimeric brain/cardiac
Na+ channels for isoform-specific LqTx binding.
A, alignment of the IVS3-S4 sequence of brain (rIIa) and
cardiac (rH1) Na+ channels and three chimeric brain
channels containing the indicated site-directed changes to substitute
cardiac sequence. Lowercase letters indicate positions with
nonconservative amino acid changes. B, displacement of bound
125I-LqTx with unlabeled LqTx was measured with tsA-201
cells transiently expressing wild-type rIIa ( ), rH1 ( ), Chim1
( ), Chim2 ( ), and Chim3 ( ) channels. Curves were normalized
and fit as described and the apparent affinities from these fits were
3.6 nM for rIIa, 12.8 nM for rH1, 4.6 nM for Chim1, 4.2 nM for Chim2, and 23.1 nM for Chim3. C, summary of affinities from
three to five separate experiments. Paired t tests were used
to assess significant differences from rIIa affinity (p < 0.05, *).
Transient Expression in tsA-201 Cells
Expression of
Na+ channels for 125I-LqTx binding was begun by
plating 20,000 tsA-201 cells/cm2 in a 150-mm tissue culture
plate on the day before transfection. Cells were transfected with 55 µg of pCDM8 vector containing the rIIa Na+ channel
cDNA using calcium phosphate/DNA coprecipitation (35). Twenty to
24 h later, these cells were subcultured by rinsing twice with
phosphate-buffered saline and treating with a solution containing 1 mg/ml trypsin and 2 mM EDTA for several minutes at room
temperature. Due to the high residual calcium and high cell density,
this solution was required to adequately remove cells and disperse them
for secondary plating. The cells were then rinsed from the plate with
culture medium, centrifuged, and thoroughly resuspended in 50 ml of
supplemented media. In order for these cells to adhere and allow
-scorpion toxin binding to intact cells, 24-well tissue culture
plates were treated for 5 min with 0.5 mg/ml poly-D-lysine,
then aspirated and rinsed twice with phosphate-buffered saline. Treated
plates were used on the day of preparation, as plates stored overnight
gave unusually high background binding of 125I-LqTx. Two ml
of transfected cells were plated per well (~500,000 cells/well), and
the cells were returned to the incubator overnight for binding on the
following day.
Na+ channels were transiently expressed for saxitoxin
binding by transfecting in 100- or 150-mm plates as described above and
maintained on the transfected plates until collection for binding
40-48 h after transfection.
Transient expression for electrophysiological analysis of
Na+ channels was done by calcium phosphate-mediated
co-transfection of 200,000 tsA-201 cells in a 35-mm dish with a 10:1
molar ratio of Na+ channel expression plasmid and
pEBO-pCD-leu2, a vector encoding the CD8 antigen, as described (35).
Transfected cells were split 10-20-fold on the day following
transfection, then analyzed 40-72 h after transfection. Cells
expressing the CD8 antigen were identified by incubation with
polystyrene microspheres precoated with anti-CD8 antibody (36), and
used for electrophysiological recording.
125I-LqTx Binding to Stably and Transiently
Transfected Cells
125I-LqTx binding to transfected
cells was performed as described (27) with the addition of 10 µg/ml
gramicidin A to the binding solution to increase the membrane
potential. Depending on expression efficiency, total
125I-LqTx bound per well ranged from 0.2 to 6 fmol/well and
nonspecific binding accounted for 0.05 to 0.08 fmol/well. Total cell
protein ranged from 400 to 800 µg/well using bovine serum albumin as
a standard in a modified Lowry protein assay (37).
[3H]Saxitoxin Binding to Intact Cells
Cell
washes, preparation, and saxitoxin binding were all done on ice with
1XP solution containing no bovine serum albumin essentially as
described (38). Transfected cells on 100- or 150-mm dishes were rinsed
twice with 5 ml of 1XP (130 mM choline chloride, 50 mM Hepes-Tris (adjusted with Tris base to pH 7.4), 5.5 mM glucose, 0.8 mM MgSO4, and 5.4 mM KCl), scraped into 10 ml of 1XP, and placed in 15-ml
polystyrene tubes (Falcon 2509). Cells were sedimented at 200 × g for 5 min at room temperature in a clinical centrifuge,
and the pellet was resuspended in 1 ml of 1XP per 8000 cm2
of plate area. For a 250-µl binding reaction, 200 µl of cell
suspension, 25 µl of 1-100 nM
[3H]saxitoxin in 1XP, and 25 µl of 1XP or 100 µM TTX were combined in a 3-ml polypropylene tube (Falcon
2063) and incubated 1 h at 4 °C. Reactions were then filtered
over GF/C filters (Millipore) under vacuum, washed twice with ice-cold
choline wash solution (163 mM choline chloride, 5 mM Hepes-Tris, 1.8 mM CaCl2, and
0.8 mM MgSO4, pH 7.4), and bound radioactivity
was detected by liquid scintillation counting. For the wild-type
channel, nonspecific binding accounted for 11-27% of the total
binding.
Ligand Binding Analysis
Results of displacement or
saturation binding experiments were analyzed using the iterative
fitting programs EBDA and LIGAND (Elsevier Biosoft, UK). A Student's
t test (paired or unpaired as appropriate) was used for
statistical comparisons of toxin affinities, using p < 0.05 as the criterion of statistical significance.
Electrophysiological Analysis
Whole cell voltage clamp
experiments were performed as described previously (39) using solutions
that contained 90 mM CsF, 50 mM CsCl, 10 mM CsEGTA, 10 mM NaF, 2 mM
MgCl2, 10 mM Hepes (pH 7.4) in the pipette and
70 mM NaCl, 70 mM
N-methyl-D-glucamine, 5 mM CsCl, 1.8 mM CaCl2, 1 mM MgCl2,
10 mM glucose, and 10 mM Hepes (pH 7.4) in the
bath. Except where noted in the figure legends, LqTx was incubated with
the cells for 30 min at 37 °C before the beginning of the
experiment. Data collection was initiated 10 min after breaking the
cell membrane to obtain the whole cell voltage clamp configuration.
RESULTS
-Scorpion Toxin Binding to Stably and Transiently Expressed
Na+ Channels
Previous experiments have shown that
mammalian cells stably expressing only the subunit of the type IIa
Na+ channel bind LqTx with a 2- to 3-fold lower affinity
than found with rat brain synaptosomes or neuroblastoma cells in
culture (27). These non-neuronal cells have a more positive resting
membrane potential than neuroblastoma
cells.2 As LqTx binding is inhibited by
depolarization, gramicidin was used to increase the resting membrane
potential and binding affinity. In the Na+-free,
choline-substituted isotonic solution used for binding assays,
gramicidin allows K+ efflux without choline influx (40) to
increase the negative membrane potential. Addition of gramicidin
increased the receptor occupancy at 0.2 nM
125I-LqTx by reducing the apparent KD
from 5.4 ± 3.1 nM to 2.0 ± 0.6 nM in CNaIIa-1
cells (mean ± S.D.; Fig. 1A). This
reduction in apparent KD is consistent with a
coincident increase in membrane potential and binding affinity, and
results in an LqTx affinity identical to that seen in neuroblastoma
cells (17).
Fig. 1.
Binding of -ScTx to stably and transiently
expressed sodium channel -subunits. A, binding of 0.2 nM 125I-LqTx to CNaIIa-1 cells (27) in the
absence ( ) and presence ( ) of 10 µg/ml gramicidin A. Displacement curves were fit using Sigmaplot (Jandel Scientific) with
the equation, Bound = Bmax/(1 + KD/[LqTx]) + c, where c
corresponds to the nonspecific binding component. Inset,
Scatchard transformation of the displacement curves indicating LqTx
affinities of 1.8 nM ( ) and 5.4 nM ( ).
B, binding of 125I-LqTx in the presence of 10 µg/ml gramicidin and 5.4 mM KCl to tsA-201 cells
transiently transfected with empty pCDM8Sal vector ( ) or pCDM8Sal-NC
constructs containing the wild type rIIa ( ), D343N ( ),
E330K/E332K/D334K ( ), and D317N/E318K/E321K/D322N Na+
channels ( ). To test the effect of depolarization,
125I-LqTx binding was also performed in gramicidin and 60 mM KCl (instead of the normal 5.4 mM KCl) with
cells transiently expressing wild type Na+ channels ( ).
Inset, Scatchard transformation of the displacement curves
indicating LqTx affinities of 2.6 ( ), 3.8 ( ), 3.9 ( ), 3.4 ( ), and 7.7 ( ) nM.
For analysis of mutations, Na+ channels were expressed in
the tsA-201 subclone of human embryonic kidney cells (HEK 293) (35).
Fig. 1B illustrates LqTx binding to cells transfected with
an expression vector containing no Na+ channel sequence or
containing the rIIa subunit cDNA. Cells transfected with the
empty vector exhibited no specific binding of 125I-LqTx,
whereas cells expressing wild-type or modified channels specifically
bound 0.7-1.25 fmol of 125I-LqTx per well in the presence
of 0.5 nM labeled toxin and gramicidin. A Scatchard
transformation of these results yielded KD values
for LqTx binding to wild-type or selected mutant channels between 2.6 and 3.9 nM and Bmax values of 28-50
pM, corresponding to 5.6-10 fmol/culture well (Fig.
1B, inset). In this transient expression system, wild-type
Na+ channels and those containing site-directed mutations
are expressed with varying efficiency depending on the mutation,
plasmid preparation, and preparation of the calcium phosphate
precipitate. Analysis of LqTx binding to the wild-type Na+
channel at levels ranging from 0.1 to 6 fmol of specific
125I-LqTx binding per well (0.2-10 fmol/mg of cell
protein) indicated no effect of expression level on LqTx affinity.
Depolarization with a high extracellular K+ concentration
would be expected to decrease binding affinity by decreasing the
K+ equilibrium potential and the resting membrane
potential. To test this, cells transiently expressing the wild-type subunit were tested in an isotonic binding solution containing
gramicidin and either 5.4 or 60 mM extracellular
K+ (Fig. 1B). Depolarization with high
extracellular K+ increased the apparent
KD of wild-type Na+ channels expressed
in tsA-201 cells from 3.2 ± 0.2 to 8.3 ± 0.7 nM.
Charge Mutations in the Subunit of the rIIa Na+
Channel
Extracellular loops in domains I and IV of the
Na+ channel subunit have been implicated in
-scorpion toxin binding (28, 29), and basic amino acids of
-scorpion and sea anemone toxins are thought to be important for
interaction with the receptor site (10, 11, 12, 13, 14, 15, 16). In order to test the role
of acidic amino acids in the extracellular loops of these two domains
in toxin binding, conserved extracellular acidic residues were altered
individually or in clusters to neutral or positively charged residues
using oligonucleotide-directed site-specific mutagenesis (Table
I). The extracellular acidic residues Asp384
and Asp1717 in domains I and IV were not tested because
they have been shown to affect ion conductance as well as the binding
of saxitoxin and tetrodotoxin (4). Since the receptor sites for
saxitoxin and -scorpion toxin do not interact (17), and -scorpion
toxins do not affect ion conductance (41, 42), these residues were
considered unlikely to participate in -scorpion toxin binding.
Mutant Na+ channels were expressed transiently in tsA-201
cells and tested for displacement of 0.5 nM
125I-LqTx with unlabeled LqTx. Surprisingly, all of these
altered channels appeared identical to wild type with the exception of
E1613R and E1613H, which showed no specific binding of
125I-LqTx (Table I). Receptor occupancy for 0.5 nM 125I-LqTx binding to the wild-type channel
(KD = 2.8 nM) is less than 0.2, and a
25-fold reduction in affinity would decrease receptor occupancy to
undetectable levels in our experiments. Thus, E1613R and E1613H may be
poorly expressed, or they may have greater than 25-fold reduction in
affinity.
[3H]Saxitoxin Binding to Mutants at
Glu1613
To test the level of expression of these
Glu1613 mutations, tsA-201 cells were transiently
transfected with control vectors or with E1613R or E1613H and assayed
for [3H]saxitoxin binding. Cells were prepared for
saxitoxin binding in an isotonic solution with gentle homogenization to
assess the level of cell surface expression. Cells transfected with an
empty expression vector showed no specific saxitoxin binding, whereas
those transfected with the wild-type Na+ channel construct
expressed 145 ± 48 fmol of specific saxitoxin receptor sites/mg of
cell protein when assayed in the presence of 5 nM
[3H]saxitoxin (n = 5). Cells expressing
E1613R or E1613H showed a level of saxitoxin binding very similar to
that of wild type (Fig. 2A), indicating that
these channels reach the cell surface and that the mutation of
Glu1613 does not significantly disrupt saxitoxin binding.
These results indicate that loss of -scorpion toxin binding in
E1613R channels is caused by reduced affinity for -scorpion
toxin.
Fig. 2.
[3H]Saxitoxin binding to
transiently expressed Na+ channels. A, tsA-201
cells were transfected with empty pCDM8Sal, pCDM8Sal.NC, or three
constructs containing site-directed mutations that showed no specific
125I-LqTx binding. Each construct was tested two to four
times in a total of five experiments. To correct for different
expression efficiencies between experiments, binding results from each
experiment were normalized to the total [3H]saxitoxin
binding of cells expressing the wild-type rIIa Na+ channel
in that experiment. The normalized results were averaged between
experiments and plotted (mean ± S.D.). B, saturation
binding of 0.1 to 11 nM [3H]saxitoxin to
tsA-201 cells transiently expressing wild type ( , solid
line) or E1613R ( , dotted line) Na+
channels was carried out for 1 h at 4 °C in the absence or
presence of 500 nM TTX. Results were analyzed with
LIGAND/EBDA and plotted. Apparent affinities from this Scatchard plot
were 0.28 nM for the wild-type channel and 0.29 nM for the E1613R channel.
To further test the specificity of the E1613R mutation, the saxitoxin
binding affinities were determined for transiently expressed wild-type
and E1613R channels. Scatchard analysis of these data indicates that
the KD for saxitoxin binding to E1613R is 0.30 ± 0.03 nM (mean ± S.E.; n = 3),
essentially identical to that for the wild-type channel (0.28 ± .02 nM, n = 3, Fig. 2B). These values for
saxitoxin affinity are in close agreement with
[3H]saxitoxin binding to mammalian cells stably
expressing the rIIa subunit in the absence and presence of
1 subunits (38). Thus, this mutation is specific in that
it does not disrupt channel expression or saxitoxin binding
affinity.
Glu1613 is conserved in cloned rat brain Na+
channels (30, 31, 32) and is an Asp in the cardiac Na+ channel
(34) as well as in the skeletal muscle, Drosophila para, eel
electroplax, and squid Na+ channels. Most alignments
(e.g. Refs. 30, 32, and 34) predicted Glu1613 to
be within the IVS3 transmembrane segment, but two analyses predicted
that this residue is located at the extracellular end of the IVS3
transmembrane segment (43, 44). We found that analysis of the rIIa
sequence from Thr1591 to Arg1626 by the Predict
Protein program (45) also predicted Glu1613 to be on the
extracellular surface.
Importance of Charged Amino Acids in the IVS3-S4 Extracellular Loop
for -Scorpion Toxin and ATX II Binding
To test the specificity
of interaction between Glu1613 and -scorpion toxin,
Glu1613 was changed to either Asp or Gln and LqTx affinity
was determined. Although neither of these mutations caused a
statistically significant change in LqTx binding affinity
(p > 0.05), the E1613Q mutation may slightly decrease
LqTx affinity (p < 0.1 for n = 3, Fig.
3A). In addition, the role of the basic
residue at the extracellular end of the IVS4 segment in -scorpion
toxin binding was tested by changing Arg1626 to a neutral
or acidic residue. These changes had no significant effect on LqTx
affinity (Fig. 3A).
Fig. 3.
Apparent LqTx and ATX II affinities of type
IIa Na+ channels containing charge and alanine-scanning
mutations in the IVS3-S4 extracellular loop. A and
C, Na+ channels containing charge or alanine
scanning mutations in the IVS3-S4 loop (residues 1613 to 1626) were
tested for displacement of bound 125I-LqTx with unlabeled
LqTx and fit with LIGAND/EBDA. Results of 3-18 determinations with
each mutation are presented as box plots, where the
box represents a 95% confidence interval of the median, the
solid and dashed lines mark the median and mean
of the data, whiskers show the main body of the data, and
outliers are plotted individually. B and
D, these altered Na+ channels were also tested
for the ability of ATX II to displace bound 125I-LqTx, and
IC50 values were converted to KI values
using the calculated -ScTx affinities and the equation
KI = (IC50/(1 + [125I-LqTx]/KD, LqTx). Results are
presented as box plots, with asterisks indicating
KI values significantly different from the
KI of wild-type channels (p < 0.05).
Since -scorpion toxins and sea anemone toxins share a common binding
site (18), the ATX II affinity of these mutant channels was also tested
by competition for 125I-LqTx binding with unlabeled ATX II
(Fig. 4, open squares). The
KD of type IIa Na+ channels for ATX II
was 76 ± 6 nM. E1613D significantly increased ATX affinity
(13 ± 3 nM; p < 0.05) while E1613Q caused
a smaller increase in affinity (Fig. 3B). Substitutions of
Arg and His at position 1613 could not be tested because these mutants
do not bind LqTx detectably.
Fig. 4.
Displacement of bound 125I-LqTx
from alanine-scanning mutants of the rIIa channel IVS3-S4 loop with
unlabeled ATX II. tsA-201 cells transiently expressing wild type
( ), L1614A ( ), I1615A ( ), E1616A ( ), K1617A ( ), and
Y1618A ( ) were incubated for 1 h at 37 °C with 0.5 nM 125I-LqTx and increasing concentrations of
unlabeled ATX II. Unbound toxin was then removed by several washes as
described under ``Experimental Procedures,'' and bound toxin was
determined by -scintillation spectrophotometry. Data was normalized
to maximal binding (100%) and fit using the equation, Bound = Bmax/(1 + KD/[LqTx]) + c, where c corresponds to the nonspecific binding
component. Apparent IC50 values for inhibition of LqTx
binding by ATX II calculated from these fits were 101 nM
for wild type ( ), 13.9 nM for rIIa-L1614A ( ), 87.7 nM for rIIa-I1615A ( ), 296 nM for
rIIa-E1616A ( ), 27.5 nM for rIIa-K1617A ( ), and 85.1 nM for rIIa-Y1618A ( ) channels. In the presence of 0.5 nM 125I-LqTx, maximal labeled toxin bound per
well was 3.22 fmol for wild type, 2.56 fmol for L1614A, 1.39 fmol for
I1615A, 2.85 fmol for E1616A, 0.59 fmol for K1617A, and 1.35 fmol for
Y1618A channels.
Glu1616 was tested in a similar manner (Fig.
3B). E1616Q (KD = 163 ± 5 nM) and E1616R (KD = 189 ± 15 nM) both had significantly decreased affinity for ATX II.
Mutations of Arg1626 at the extracellular end of IVS4 which
neutralize or reverse the charge at this position appeared to increase
ATX affinity slightly (Fig. 3B), although not to a
statistically significant degree (p > 0.05). In
general, conversion of Glu1613, Glu1616, or
Arg1626 to more negative or shorter side chains increased
ATX II affinity, and conversion to more positive side chains decreased
affinity.
Alanine-scanning Mutagenesis of the IVS3-S4 Extracellular
Loop
Having found several charged residues in the IVS3-S4 loop
that were important for -scorpion toxin and/or sea anemone toxin
binding, the effects of mutation of residues Leu1614
through Phe1625 were then tested by conversion of each to
Ala. Two of these amino acid changes, K1617A and P1622A, were found to
significantly increase -scorpion toxin affinity (p < 0.05, Fig. 3C). The increase in affinity with these
individual mutations suggests that the positive charge and conformation
of this loop may hinder -scorpion toxin binding in wild type.
The importance of individual residues in this extracellular loop for
ATX II binding was assessed by competition with 125I-LqTx
binding as well. Replacement of five consecutive residues,
Leu1614 through Tyr1618, individually with Ala
resulted in one mutant with lower ATX II affinity (E1616A), and two
with higher ATX II affinities (L1614A and K1617A, Fig. 4). As
summarized in Fig. 3D, Ala replacements of
Leu1614, Lys1617, and Ser1621 all
significantly increased ATX II binding affinity (p < 0.05), whereas substitution of residues Glu1616,
Val1620, and Leu1624 significantly decreased
affinity (p < 0.05). The changes in affinity for
Leu1614, Lys1617, Ser1621, and
E1616A are also consistent with the generalization that shorter side
chain length and more negative charge lead to higher ATX affinity. The
reduction in affinity with the V1620A and L1624A mutations may indicate
that side chain length or hydrophobicity is important for their
interaction with ATX II, or that the folding of this loop is disrupted
with these mutations.
Surprisingly, replacement of aromatic residues Tyr1618 and
Phe1619 with Ala did not affect toxin affinity or
expression, suggesting that these residues may be oriented toward the
channel protein or membrane and are not critical for toxin binding. It
was also surprising that P1622A had normal expression and high affinity
binding, as an Ala at this position would be expected to relieve some
conformational constraints and alter a bend in this loop. Mutant F1625A
did not express sufficiently well to detect either -scorpion toxin
binding or saxitoxin binding (Fig. 2A), indicating that this
residue is probably important in channel assembly or folding.
Amino Acid Residues which Cause Differences in -Scorpion Toxin
Binding to Brain and Cardiac Na+ Channels
Cardiac
Na+ channels bind -scorpion toxin with lower affinity
than brain Na+ channels (46). Rat brain type IIa
Na+ channels expressed in tsA-201 cells have a
KD for LqTx binding of 2-5 nM (Figs. 1
and 5), whereas rat cardiac rH1 Na+ channels
have a KD of 18 nM (Fig. 5, B
and C). These two Na+ channel subunits have
several differences in amino acid sequence in transmembrane segment
IVS3 and in the IVS3-S4 extracellular loop (Fig. 5A). We
constructed chimeric Na+ channels in which the amino acid
residues in the IVS3-IVS4 segment of the rat brain type IIa subunit
were converted to those in the cardiac isoform (Fig. 5A).
Conversion of two extracellular residues (Chim1) or four extracellular
residues (Chim2) did not significantly affect LqTx affinity (Fig. 5,
B and C). The lack of significant effects of
these extracellular mutations on -scorpion toxin affinity is
consistent with the results of alanine-scanning mutants (Fig. 3). In
contrast, conversion of seven amino acid residues in this region,
including three residues predicted to be in transmembrane segment IVS3,
reduced LqTx affinity to a level similar to that of the cardiac
Na+ channel (Chim3, KD = 24 nM, Fig. 5, B and C). This result
suggests that residues at the extracellular end of the IVS3
transmembrane segment confer isoform-specific LqTx binding properties
on the -scorpion toxin receptor site. We also analyzed the binding
of LqTx to chimeras in which each of the other 15 extracellular loops
of the rIIa subunit had been individually replaced with the
corresponding amino acids from the rH1 subunit.2 All of
these chimeras had KD values for LqTx which were
identical to rIIa channels, indicating that the amino acid residues
near the extracellular end of the IVS3 transmembrane segment may be
primarily responsible for differences in LqTx binding between cardiac
and neuronal Na+ channels.
Electrophysiological Properties of Na+ Channels
Containing Mutations of Glu1613
To determine the
toxin affinity and electrophysiological properties of the E1613R and
E1613H mutants, wild-type and mutant channels were transiently
expressed in tsA-201 cells and analyzed by whole cell voltage clamp.
The Na+ currents elicited by depolarization of cells
expressing wild-type, E1613R (Fig. 6), or E1613H (not
shown) appeared identical in time course without LqTx present. The
voltage eliciting half-maximal activation (V1/2)
from a holding potential of 140 mV was 19.3 ± 3 mV for wild-type
rIIa channels (n = 3), 20.9 ± 2.3 mV for E1613R
(n = 5), and 30.5 ± 3.7 mV for E1613H
(n = 3) (data not shown). The V1/2
for steady-state inactivation was 59.0 ± 2.9 mV (n = 5) for wild-type channels, 61.4 ± 2.7 mV for E1613R
(n = 5), and 74.0 ± 0.4 mV for E1613H
(n = 3) (data not shown). Thus, the voltage dependence
of channel activation and inactivation was very similar for wild type
and E1613R, but both of these parameters were shifted in the
hyperpolarized direction for E1613H.
Fig. 6.
Electrophysiological effect of LqTx and ATX
II on wild-type and E1613R Na+ channels transiently
expressed in tsA-201 cells. Cells expressing the rIIa wild-type
Na+ channel subunit (A and C) or
rIIa-E1613R (B and D) were held at 140 mV and
Na+ currents were elicited with a 25-ms step to 10 mV.
LqTx or ATX II was added in bath solution with 10-fold higher toxin
concentration, allowed to equilibrate for 5-10 min, and
Na+ currents were recorded as described under
``Experimental Procedures.'' Na+ currents elicited in the
presence of the indicated final toxin concentrations are shown.
A: 1, control; 2, 20 nM
LqTx. B: 1, control; 2, 20 nM LqTx; 3, 200 nM LqTx.
C: 1, control; 2, 1 nM
ATXII; 3, 10 nM ATXII. D:
1, control; 2, 10 nM ATXII;
3, 100 nM ATXII.
Affinity of Na+ Channels Containing Mutations at
Glu1613 for LqTx and ATX II
In the absence of toxin,
Na+ conductance through wild-type Na+ channels
decays to approximately 5% of the peak within 2 ms. In contrast, after
addition of a saturating concentration of LqTx (20 nM) up
to 70% of the current remains after 2 ms (Fig. 6A). Mutant
E1613R was more than 10-fold less sensitive to -scorpion toxin,
since 200 nM toxin caused less slowing of inactivation for
the mutant than 20 nM did for wild-type (Fig.
6B).
To determine the KD for LqTx, transiently expressed
wild-type or mutant Na+ channels were incubated with
varying concentrations of LqTx for 30 min at 37 °C. Cells were then
voltage clamped at a holding potential of 140 mV, and currents were
elicited by a depolarizing pulse to 10 mV. The fraction of
conductance remaining 2 ms after the peak is proportional to the number
of channels modified by -scorpion toxin, and this fraction can be
used to estimate receptor occupancy and toxin affinity according to the
formula,
|
(Eq. 1)
|
where FG is the fraction of Na+
current remaining 2 ms after the beginning of the pulse, and
G is the maximum fraction of current 2 ms
after the beginning of the pulse in the presence of a saturating
concentration of -scorpion toxin (1 µM, Ref. 47). From
this analysis, the KD for LqTx binding was 1.7 nM for the wild-type channel, 14 nM for E1613H,
and 106 nM for E1613R channels (Table
II).
Table II.
Effects of mutations of Glu1613 on binding of LqTx and ATX II
The indicated amino acids were substituted for Glu1613 by
oligonucleotide-directed mutagenesis, the resulting mutant Na+
channels were expressed in tsA-201 cells, and the KD
values for binding of LqTx and ATX II were measured as described in
Fig. 6 and the text.
| Mutant |
Loop |
Q |
KD
(LqTx) |
n |
KD (ATX
II) |
n
|
|
|
|
|
nM |
|
nM
|
| Wild
type |
IVS3-S4 |
0 |
1.71
± 1.1 |
5 |
3.3 ± 2.0 |
6
|
| E1613H |
IVS3-S4 |
+1 |
14.0
± 4.0 |
3 |
|
| E1613R |
IVS3-S4 |
+2 |
106 ± 14 |
6 |
268
± 160 |
6 |
|
Similar experiments were carried out for ATX II binding to mutant
E1613R. Addition of 1 nM ATX II slowed the inactivation of
a significant fraction of wild-type Na+ channels, and 10 nM slowed inactivation of most wild-type Na+
channels (Fig. 6C). Averaged results indicated a
KD value at 140 mV of 3.3 nM (Table
II). A concentration of 100 nM ATX II was much less
effective in slowing inactivation of E1613R than 10 nM ATX
II was in slowing wild type (Fig. 6D), and averaged results
indicated a KD value of 270 nM for
E1613R (Table II). Thus, the E1613R mutation reduces the affinity for
LqTx 62-fold and the affinity for ATX II 82-fold. These results are
consistent with the conclusion that Glu1613 is an integral
component of overlapping binding sites for both -scorpion toxins and
sea anemone toxins.
Electrophysiological Determination of the Kinetics of LqTx Binding
to Wild-type, E1613R, and E1613H Channels
Binding of -scorpion
toxins is reversible, and the difference in toxin affinity at
equilibrium is a reflection of differences in the kinetic rate
constants for toxin association and/or dissociation. Previous
biochemical and electrophysiological work has shown that -scorpion
toxin binding is inhibited by depolarization due to acceleration of
toxin dissociation (17, 18, 19, 20, 21, 22). In order to compare the rates of toxin
dissociation from these channels, strong depolarizing pulses of
increasing duration were used to follow the time course of toxin
dissociation from wild-type, E1613R, and E1613H channels. tsA-201 cells
transiently expressing each channel were incubated in 100 nM LqTx for 30 min at 37 °C, voltage clamped to 120 mV
to stimulate maximum toxin binding, and then depolarized to +100 mV for
intervals from 9 to 89 ms to induce toxin dissociation, repolarized
briefly to 120 mV to reverse channel inactivation, and depolarized to
0 mV for measurement of Na+ current (Fig.
7A, inset). This protocol was repeated with
10-ms increments in the duration of the interval at +100 mV to yield
the series of traces in Fig. 7A. Progressively faster
Na+ channel inactivation was observed with each 10-ms
increment at +100 mV, until essentially complete dissociation of the
toxin and loss of toxin effect was reached during 89-ms prepulses to
+100 mV for wild type (Fig. 7A).
Fig. 7.
Determination of the
voltage-dependent dissociation rates of LqTx. A,
cells transiently expressing the wild-type Na+ channel were
incubated in 100 nM LqTx for 10 min at a holding potential
of 120 mV to allow binding. The rate of toxin dissociation at +100 mV
was determined with the illustrated pulse paradigm by stepping to a
conditioning pulse of +100 mV for 9 to 89 ms (cond), returning to 120
mV for 20 ms to recover from fast inactivation, then eliciting
Na+ current with a 10-ms test pulse to 0 mV (test). Traces
show the acceleration of inactivation due to toxin dissociation with
longer conditioning pulses. A new steady-state was reached after
79-89-ms conditioning pulses. By using conditioning pulses to other
potentials, the time course of dissociation at other potentials was
also determined. B, kinetics of dissociation of 2 nM LqTx from cells expressing the wild-type Na+
channel using the same protocol at conditioning potentials of +60 mV
( ), +80 mV ( ), and +100 mV ( ). The ratio of current 2 ms after
the depolarizing step relative to peak current was plotted in order to
normalize for the change in peak Na+ current resulting from
slow inactivation and to determine the extent of inactivation removal
by LqTx. Toxin dissociation was fit with a single exponential function
with the following time constants: +100 mV = 37.2 ms,
+80 mV = 76.4 ms, and +60 mV = 209.2 ms.
C, the time course of dissociation of 100 nM
-ScTx from cells expressing the E1613R was determined at +100 mV
( , = 3.7 ms), +80 ( , = 5.5 ms), +60 ( , = 12.4 ms),
+40 ( , = 16.9 ms), +20 ( , = 26.4 ms), and 0 ( , = 47.1 ms). D, time courses of dissociation of 100 nM -ScTx from E1613H at +100 mV ( , = 4.0 ms), +80
mV ( , = 6.3 ms), +60 mV ( , = 9.5 ms), +40 mV ( , = 19.1 ms), and +20 mV ( , = 40.5 ms).
The time course of toxin dissociation was determined for wild-type and
mutant Na+ channels at a range of membrane potentials using
the protocol described in Fig. 7A. By plotting the ratio of
current at 2 ms after the peak to the current at the peak as a function
of dissociation time during the positive prepulses, the loss of toxin
action with increasing prepulse duration was determined and fit with a
single exponential equation (Fig. 7, B-D). For wild-type,
the time constant of toxin dissociation at +100 mV was 37.2 ms (Fig.
7B), but this time constant was 3.7 ms for the E1613R
channel (Fig. 7C) and 4.0 ms for the E1613H channel (Fig.
7D). Comparison of the time constants of toxin dissociation
at different potentials and toxin concentrations showed that the rates
of toxin dissociation from all three channels were
voltage-dependent, with more rapid dissociation during
stronger depolarizations, and were concentration-independent (Fig. 7,
B-D). The wild type channel has the slowest dissociation at
all membrane potentials, and the E1613R mutant has the fastest (Fig. 7,
legend). These rapid dissociation rates may reflect the rate and
voltage dependence of the change of channel state induced in the
toxin-channel complex by the voltage change from 90 mV to +100 mV as
well as the rate of dissociation of the toxin-channel complex
itself.
The rates of toxin association were assessed for the wild-type and
mutant channels using a 200-ms prepulse to +100 mV to cause toxin
dissociation followed by progressively longer hyperpolarizing prepulses
to follow the time course of toxin re-binding and action. Fig.
8A shows the stimulus protocol and the
cumulative slowing of inactivation as toxin reassociates with the
wild-type channel. The first Na+ current recorded 102 ms
after repolarization to 120 mV was rapidly inactivating; more slowly
inactivating currents were recorded following progressively longer
hyperpolarizing prepulses as toxin binding approached equilibrium. The
time courses of toxin association at several different potentials were
determined for wild-type and mutant channels using this protocol. The
association kinetics were fit with a single exponential time constant,
which was 548 ± 208 ms for wild-type at 100 mV (n = 4, Fig. 8B), 429 ± 49 ms for E1613R (n = 3, Fig. 8C), and 365 ± 204 ms for the E1613H
(n = 5, data not shown). By comparing the time
constants measured at a range of voltages (Fig. 8, legend), the rate of
toxin association at negative potentials was found to be
voltage-independent, and similar for wild-type and mutant channels.
Fig. 8.
Determination of rates of LqTx association to
transiently expressed Na+ channels at different membrane
potentials. A, cells transiently expressing the wild-type
Na+ channel were incubated in 100 nM LqTx for
10 min at a holding potential of 120 mV to establish binding. A
200-ms depolarizing step to +100 was then used to dissociate all of the
bound toxin and the cell was returned to 120 mV for increasing
durations (102, 202, 402, 602, 1102, 2102, 3102, or 4102 ms, see
diagram) before testing the extent of inactivation removal with a 10-ms
test pulse to 0 mV. The pulse following 102 ms at 120 mV elicited a
rapidly inactivating current. Subsequent cycles with longer re-binding
periods at 120 mV elicited Na+ currents with successively
slower inactivation kinetics until equilibrium was reached. Re-binding
periods at different potentials (e.g. 100 and 80 mV)
were used to assess the voltage dependence on LqTx association.
B, kinetics of association of 100 nM LqTx to
cells expressing the wild-type Na+ channel using the same
protocol at conditioning potentials of 80 mV ( ) and 100 mV
( ). The ratio of current 2 ms after the depolarizing step relative
to peak current was plotted in order to normalize for the change in
peak current and to determine the extent of inactivation removal by
LqTx. The association time courses were fit by single exponential time
constants of  80 mV = 639.6 ms and  100
mV = 550.5 ms. C, association rates for LqTx binding
to cells transiently expressing E1613R at 60 mV ( , = 695.8 ms), 70 mV ( , = 520.8 ms), 80 mV ( , = 388.1 ms), 90
mV ( , = 506.1 ms), 100 mV ( , = 440.9 ms), 110 mV
( , = 463.4 ms), and 120 mV ( , = 485.5 ms). The LqTx
occupancy at 40 mV ( ) was too low to fit.
Fig. 9 compares the voltage dependence of time constants
for LqTx association and dissociation. The time constants for
association of LqTx between 120 and 60 mV appeared unaffected by
voltage and were similar for both of these channels (Fig.
9A) and for E1613H (not shown). In contrast, the
dissociation rates were much faster for the E1613R channels and were
strongly voltage-dependent, with more depolarized
potentials significantly accelerating dissociation (Fig.
9B). A semilog plot of the voltage dependence of toxin
dissociation from E1613R channels was linear between 0 and +100 mV and
indicated an e-fold increase in toxin dissociation rate for
every 36.4 mV of depolarization. Similar experiments with the wild-type
channel were more difficult as the dissociation rate was much slower
and could only be measured above +60 mV. However, using the
dissociation rates at +60, +80, and +100 mV (Fig. 9B), the
toxin dissociation rate for wild-type channels was found to increase
e-fold for every 22-25 mV. Although the narrow voltage
range examined and the much slower dissociation rate for the wild-type
channel make the comparison difficult, it appears that the voltage
dependence of the rate of toxin dissociation is less steep for mutant
E1613R than for wild type in this positive voltage range.
Fig. 9.
Summary of association and dissociation time
constants for binding of LqTx to wild-type and E1613R Na+
channels. A, mean time constants of LqTx association to
wild-type ( ) and E1613R ( ) channels at different recovery
potentials. B, mean time constants of LqTx dissociation from
wild-type ( ) and E1613R ( ) channels at different conditioning
potentials. Data were fit with single exponential constants of 22.4 mV
and 36.4 mV, respectively, and plotted on a semi-log scale.
Voltage Dependence of Toxin Binding at Equilibrium
Previous
models describing the voltage dependence of -scorpion toxin binding
have proposed two receptor states with high and low toxin affinities.
These states are in reversible equilibrium described by a
voltage-dependent, allosteric equilibrium constant (17, 19,
22). A negative membrane potential favors the high affinity
conformation, depolarization favors the low affinity conformation, and
intermediate voltages reveal a distribution of receptor affinities as
described by the Monod-Wyman-Changeux model for allosteric modulation
of oxygen binding to hemoglobin (17, 19, 48). Mutations of
Glu1613 may cause a reduction in binding affinity by
directly disrupting binding, or by indirectly shifting the
voltage-dependent allosteric equilibrium constant. By
measuring the extent of toxin association at equilibrium at a range of
negative membrane potentials, the KD values for LqTx
binding at voltages between 120 mV and 0 mV for wild-type and E1613R
channels were determined (Fig. 10, A and
B, circles). With both channels, the
voltage-dependent affinity change was sigmoidal, with the
conversion between high and low affinity states occurring between 80
and 40 mV. Fitting with the Boltzmann equation yielded a
V1/2 value for the affinity change of 55 ± 5.9 mV
(n = 3) and a slope factor of e-fold per 4.6 ± 1.7 mV for wild-type channels and a V1/2 of
51.6 ± 1.8 mV (n = 3) and slope factor of
e-fold per 4.2 ± 0.4 mV for E1613R channels (Fig. 10,
legend). Similar results were obtained with mutant E1613R when the
extent of toxin dissociation at equilibrium was measured (Fig.
10B, squares). At potentials more negative than
100 mV, the KD values for wild-type and E1613R
channels were 1.7 and 106 nM, respectively. At +40 to +100
mV, the KD values were 26 and 800 nM,
respectively. These results indicate that, although the binding
affinities of these channels differ by over 60-fold at 100 mV, the
voltage dependence of LqTx binding to these channels at equilibrium is
similar.
Fig. 10.
Voltage dependence of LqTx binding at
equilibrium. A, for cells transiently expressing the
wild-type rIIa Na+ channel, a variation of the on-rate
protocol was used (Fig. 8) after incubation with 2 nM LqTx
for 30 min. A 200-ms pulse to +100 mV was applied to cause complete
toxin dissociation followed by repolarization for 100 ms at 120 mV to
recover from fast inactivation and a 10-ms test pulse to 0 mV to assess
toxin dissociation. For determination of steady-state binding at each
potential, a 2000-ms pulse to the indicated binding potential ( 100 to
0 mV) was used to allow LqTx to bind the channel, followed by a 100-ms
period at 120 to recover from fast inactivation and a 10-ms test
pulse to 0 mV. This was repeated 11 or 16 times in order to reach
steady-state at each binding potential. KD was
calculated with the equation KD = [LqTx]/( G/FG 1) as
described in the text and plotted as a function of the voltage at which
binding was monitored. The values of KD were fit
with a Boltzmann equation (solid line) of the form
KD = 1/(1-exp((V V1/2/k),
where V1/2 is the potential giving
half-maximal affinity and k is the slope factor. For this
cell the V1/2 was 55 mV and the slope factor
was 3.8 mV. The mean values were V1/2 = 55 ± 5.9 mV and k = 4.6 ± 1.7 mV (n = 3). B, binding of LqTx to cells expressing E1613R was
assessed using steady-state binding with both the on-rate (Fig.
8C, ) and off-rate (Fig. 7C, ) protocols.
Steady-state binding following dissociation was monitored at positive
potentials with E1613R because of the rapid dissociation, low affinity,
and large amount of toxin required for association at these potentials.
A Boltzmann fit (solid line) gave values for this cell of
V1/2 of 50.8 mV and k = 4.6 mV. The mean values were V1/2 = 51.6 ± 1.8 mV and k = 4.2 ± 0.4 mV (n = 3).
By combining the equations KD = k 1/k1 and = (k1 + k 1) 1, the KD
values determined at each potential, and the association and
dissociation time constants determined above, the corresponding
dissociation (k 1) or association
(k1) rate constants could be calculated using
the equations
|
(Eq. 2)
|
and
|
(Eq. 3)
|
At negative potentials, the KD and association
time constants for LqTx binding to wild-type and E1613R channels were
approximately constant between 120 and 80 mV (Figs. 9 and 10),
indicating that the dissociation rate did not change substantially over
this voltage range. Using the assoc rates from several
experiments at 100 mV and KD values at 100 mV of
1.7 and 106 nM for the wild-type and E1613R channels, the
association rate constants were calculated to be 1.8 × 107
and 2.2 × 107 M 1
s 1, respectively. Using the equation
k 1 = KD · k1 and the KD values
determined between 120 and 80 mV (Fig. 9), the calculated
k 1 values in this voltage range were 3.1 × 10 2 s 1 and 2.3 s 1 for the
wild-type and E1613R channels, respectively.
DISCUSSION
High Affinity -Scorpion Toxin Binding to Transiently Expressed
Na+ Channels
Voltage-gated Na+ channels
can be functionally expressed in a variety of nonexcitable cells. Our
results show that LqTx binding with the high affinity characteristic of
neurons can be observed for Na+ channels expressed in
tsA-201 cells if the membrane potential of the cells is hyperpolarized
by incubation in Na+-free medium containing gramicidin.
Thus, high affinity, voltage-dependent binding of
-scorpion toxin requires only the subunit of the Na+
channel and a sufficiently negative membrane potential. Previous
labeling of Na+ channels with photoreactive derivatives of
-scorpion toxin have shown specific incorporation into both the and 1 subunits of the Na+ channel (24, 25, 26), and
different photoreactive derivatives label the two subunits in different
ratios (26). In light of our present results, photolabeling of the 1
subunit likely represents covalent attachment of photoreactive LqTx to
an area of the 1 subunit which is near, but on the periphery of, the
-scorpion toxin receptor site on the subunit.
Glu1613 and the IVS3-S4 Loop Are Critical Determinants
of -Scorpion Toxin and ATX II Binding
Three experimental
results indicate that the IVS3-S4 extracellular loop of the
Na+ channel subunit is a critical component of the
receptor for -scorpion and sea anemone toxins. 1) Changing
Glu1613 in this loop to Arg or His dramatically reduces
LqTx and ATX II affinity. 2) Changes in either charge or size of
Glu1613 and Glu1616 in this loop significantly
affect ATX II affinity, indicating a tight interaction with these
residues. 3) Replacement of individual residues within this loop with
Ala identifies a third charged residue (Lys1617) and six
uncharged residues that significantly affect LqTx and/or ATX II
affinity. It is likely that Glu1613 and the IVS3-S4 loop
constitute an important component of neurotoxin receptor site 3, the
-scorpion toxin and sea anemone toxin receptor site.
Previous photoaffinity labeling studies led to covalent incorporation
of photoreactive -scorpion toxin derivatives into the IS5-S6 loop of
the subunit (28), and anti-peptide antibodies directed against
sequences in the IS5-SS1, ISS2-S6, and IVS5-SS1 segments of the subunit reduce -scorpion toxin binding (29). While it was suggested
that the IVS3-S4 loop may play a role in -scorpion toxin binding
(29), this extracellular loop was not experimentally identified as part
of the -scorpion toxin receptor site in previous studies, perhaps
because the site-directed antibodies and the photoreactive moiety on
the -scorpion toxin derivatives could not interact with this short
loop. Our present results show that negatively charged amino acid
residues in the IS5-S6, IVS5-SS1, and IVSS2-S6 loops are not required
for -scorpion toxin binding, but that both negatively charged and
neutral amino acid residues in the IVS3-S4 loop are required for high
affinity binding. Further mutagenesis studies will be required to
identify the individual amino acid residues in the IS5-S6, IVS5-SS1,
and IVSS2-S6 loops which also participate in toxin binding.
Acidic amino acids of the Na+ channel have been proposed to
be important for -scorpion toxin and anemone toxin binding based on
structural information about these toxins (10, 11, 12, 13, 14, 15, 16). The identification
of Glu1613 as an important determinant of -scorpion
toxin binding and Glu1613 and Glu1616 as
determinants of anemone toxin binding is consistent with an
electrostatic interaction between acidic residues of the
Na+ channel and basic residues of -scorpion toxins or
sea anemone toxins. These mutations also demonstrate that this loop
contains more determinants for binding of ATX II than LqTx, and
therefore that the receptor sites for -scorpion toxin and anemone
toxins are overlapping but not identical. Previous studies with anemone
toxins have implicated the conserved Arg14 residue in
anemone toxin binding (14). Recent mutagenesis studies of the
Anthopleurin anemone toxins found that double mutants which
neutralize both Arg12 and Arg14 in ApB have the
most dramatic reduction in affinity among the double mutants, while
mutations of residues Arg12 and Lys49 alter the
cardiac selectivity of ApA (16). Based on the residues of the
Na+ channel IVS3-S4 loop identified in toxin binding,
residues 12 and 14 of ApB may interact with Glu1613 and
Glu1616 of the Na+ channel subunit, whereas
Lys49 may interact with residues outside of this loop to
contribute to cardiac selectivity. Sea anemone toxins are different
from -scorpion toxin in many respects, including smaller size,
unique sequence, distinct three-dimensional structure, generally lower
affinities for neuronal channels and higher affinities for cardiac
Na+ channels, and weaker inhibition of binding with
depolarization (2, 7, 8, 9, 13, 14, 18, 22). Although we did not identify
acidic binding determinants in regions previously implicated in
-scorpion toxin binding (IS5-S6 and IVS5-S6; Refs. 28 and 29),
non-acidic residues in these other regions may contribute to
-scorpion toxin binding by providing unique determinants that are
involved in interactions with LqTx but not ATX II. This is consistent
with the biochemical evidence for the involvement of the IS5-S6 and
IVS5-S6 loops in toxin binding (28, 29), and with the previously
suggested concept of multiple attachments points for -scorpion toxin
binding (10, 11, 14). Our results indicate that ATX II and LqTx bind to
overlapping, but not identical, determinants in the IVS3-S4 loop which
form part of neurotoxin receptor site 3.
Amino Acid Residues in Segment IVS3 Cause Differences in
-Scorpion Toxin Binding between Brain and Cardiac Na+
Channels
Na+ channels in neurons have a significantly
higher affinity for LqTx than Na+ channels in cardiac cells
(46). Consistent with this, rat brain type IIa Na+ channels
have 4-10-fold higher affinity than rat cardiac H1 channels when
expressed in tsA-201 cells. However, the difference in binding affinity
between these two cloned and expressed channels is not as great as the
difference observed between neuronal and cardiac cells in cell culture
(65-fold, Ref. 46). This may reflect differences in the membrane
potential in different cell populations, in the voltage dependence of
toxin binding between the two Na+ channel isoforms, in the
assay methods used in the different studies (toxin-stimulated ion flux
versus toxin binding), or in the channel processing and
second messenger modulation between different cell types. Nevertheless,
our results suggest that the difference in KD for
-scorpion toxin between the rIIa and rH1 subunit isoforms
expressed in parallel in tsA-201 cells is due, at least in part, to
amino acid sequence differences in the IVS3 transmembrane segment.
These amino acid residues near the extracellular end of the IVS3
transmembrane segment may interact directly with the bound LqTx
polypeptide themselves, or they may influence the position of the
extracellular end of the IVS3 segment containing Glu1613 or
the conformation of the IVS3-S4 loop, which our results suggest are
sites of direct toxin interaction.
Kinetics of -Scorpion Toxin Binding
In our experiments,
the kinetics of -scorpion toxin binding have been determined over a
wider range of voltages ( 120 to +100 mV) than in previous studies in
order to determine rate constants and equilibrium dissociation
constants. The association rate constants determined in the present
experiments at 100 mV for wild type and E1613R (1.82 × 107 and 2.20 × 107
M 1 s 1, respectively) were
faster than the k1 value of 1.5 × 105 M 1 s 1
determined electrophysiologically at 100 mV with a scorpion toxin of
lower affinity ( LqIIa, Ref. 22), but quite similar to the
k1 value of the higher affinity AahII scorpion
toxin (k1 = 1.5 × 107
M 1 s 1) determined biochemically
(49). By using the KD values determined at 100 mV,
the corresponding calculated k 1 values of 3.09 × 10 2 s 1 and 2.33 s 1 for the
wild-type and E1613R channels, respectively, are faster than the
k 1 values determined for LqIIa or AaH II
(both 1.6 × 10 3 s 1, Refs. 22 and 49).
Thus, the association rate constants determined at negative potentials
are consistent with previous work using other -scorpion toxins, the
calculated dissociation rate constants are somewhat faster than for
those other toxins, and the difference in affinity of the wild-type and
E1613R channels at negative potentials is entirely due to the
difference in the dissociation rate.
Voltage Dependence of -Scorpion Toxin Binding at
Equilibrium
The proximity of the IVS3-S4 loop to the
voltage-sensing IVS4 transmembrane segment provides a potential
molecular basis for understanding the voltage dependence of toxin
binding and the coupling of activation to inactivation. The
voltage-dependence of equilibrium binding is well described by a
Boltzmann distribution (19-21, Fig. 10), and the
voltage-dependent changes in affinity are observed in the
same range ( 80 to 40 mV) over which voltage-dependent
gating transitions occur within the channel. The midpoint for the
voltage-dependent change in affinity for -scorpion toxin
is essentially identical for wild-type and mutant channels. The
steepness of the change in -scorpion toxin binding affinity
(k = 4.2-4.6 mV) is also similar between wild-type and
mutant channels, but is steeper than previously reported for other
-scorpion toxins binding to Na+ channels in amphibian
node of Ranvier (k = 6.0-9.8 mV, Ref. 20;
k = 9.5 mV, Ref. 21; k = 11.5, Ref.
23). Wang and Strichartz (23) noted that both the range and steepness
of voltage dependence were dependent on the toxin studied, which may
explain most of the quantitative differences in voltage dependence in
different studies. The similarity in voltage dependence of LqTx binding
to wild-type and E1613R channels indicates that the 30-60-fold change
in affinity as a result of the E1613R mutation does not strongly affect
the voltage-dependent transition between channel states in
the voltage range from 80 to 40 mV.
In our experiments, the voltage dependence of toxin binding to
transfected rIIa channels was significantly more negative than the
voltage dependence of activation, and steeper and slightly more
positive than the voltage dependence of steady-state inactivation. In
comparison to our results, the voltage dependence of -scorpion toxin
binding to neuroblastoma cells and frog sartorius muscle measured in
equilibrium binding experiments was much more positive than
steady-state inactivation and correlated approximately with the voltage
dependence of activation (17, 19), while the voltage dependence of
toxin binding to Na+ channels measured
electrophysiologically in frog node of Ranvier was 20 mV more positive
than steady-state inactivation, and was positioned between the voltage
dependence of activation and inactivation (20, 21). These differences
in voltage dependence of toxin binding relative to channel gating may
result from inherent isoform- or species-specific differences in gating
among different Na+ channels.
The process of inactivation is thought to be intrinsically
voltage-independent and to acquire its voltage dependence from coupling
to activation (50). Multiple voltage-dependent transitions
between closed states occur during the activation process (50). These
voltage-dependent transitions among closed states along the
activation pathway are likely to be responsible for
voltage-dependent coupling of activation to steady-state
inactivation and for voltage-dependent changes in affinity
for -scorpion toxins and sea anemone toxins. The voltage dependence
of transitions among closed states leading to activation falls between
that of activation and steady-state inactivation (50). The slowing of
inactivation and the reduction in the steepness of voltage-dependence
of steady-state inactivation caused by -scorpion toxins and sea
anemone toxins (2, 17, 18, 19, 20, 21, 22, 23) suggest that the toxin receptor site
undergoes a conformational change that is required for fast
inactivation, that bound toxin slows this conformational change and
thereby slows the inactivation process, and that toxin binding is
destabilized as a result of conformational changes which lead
ultimately to inactivation. Therefore, our results implicate the S3-S4
loop in domain IV of the subunit in coupling of activation to
inactivation.
Voltage Dependence of Dissociation of -Scorpion Toxin in the
Positive Potential Range
The KD for
-scorpion toxin remained constant from 40 mV up to at least +100
mV. In contrast, dissociation rates for -scorpion toxin increased
steadily between 0 and +100 mV. The rapid rates of dissociation in this
voltage range may reflect the rate of change of state of the
toxin-channel complex from a high affinity conformation at negative
membrane potentials to a low affinity conformation at positive
potentials as well as toxin unbinding itself.
Voltage-dependent dissociation is likely to be driven by
the voltage-dependent conformational change to the low
affinity state. The voltage dependence of LqTx dissociation can be fit
with a single exponential equation (21, 22, 51) and the voltage
dependence of dissociation from wild-type and E1613R channels
(e-fold/22-25 mV and e-fold/36 mV, respectively)
is similar to previous reports (e-fold/25 mV, Ref. 21;
e-fold/32 mV, Ref. 51). The significance of the apparent
difference in steepness of the voltage dependence of toxin dissociation
at positive membrane potentials between wild-type and E1613R channels
(Fig. 10) is not clear, as the voltage-dependence of equilibrium
binding in the negative voltage range where channel gating occurs is
similar between the two channels (Fig. 9). These
voltage-dependent changes in dissociation kinetics at
positive potentials may reflect voltage-dependent
transitions in the toxin-channel complex which are outside the normal
voltage range of channel gating and may differ between wild-type and
mutant channels.
A Model for Binding and Action of -Scorpion Toxins and Sea
Anemone Toxins
Na+ channel gating currents are the
most direct measurement of voltage-dependent conformational
changes in ion channels and may represent outward movement of the S4
segments (3). Both -scorpion toxin and sea anemone toxins reduce the
effective gating current, abolish the later, slower components of the
gating current, and slow or block the immobilization of gating charge
that occurs following normal channel activation (52, 53). The S4
segment in the domain IV of the Na+ channel has been shown
to move toward the extracellular space during depolarization (54).
Toxin bound across the IVS3-S4 extracellular loop may slow this
movement or subsequent conformational changes that are necessary for
fast inactivation. The S4 segments of the Electrophorus
electroplax, squid optic lobe, and all sequenced vertebrate
Na+ channels contain 4, 5, 6, and 8 positive charges in
domains I, II, III, and IV, respectively (e.g. Refs. 30, 32,
and 34). Therefore, in response to depolarization the IVS4 segment may
move further, at a different rate, or in a different voltage range than
the other voltage sensors. Translocation of IVS4 may be required for
the inactivation gate to close, and -scorpion toxin or sea anemone
toxin bound at the extracellular end of IVS4 may slow or block this
translocation, preventing inactivation and gating charge
immobilization. In fact, several mutations of the skeletal muscle
Na+ channel responsible for paramyotonia congenita also lie
within this loop at positions corresponding to Leu1614 and
Arg1624 (55). Genetic defects at these positions slow
inactivation (55), disrupt coupling of activation to inactivation (54),
and result in muscular dysfunction. Together with this previous work,
our results therefore identify a short extracellular loop of the
Na+ channel molecule that is critical for the binding of
-scorpion and sea anemone toxins and is also important for the
coupling of channel activation to fast inactivation.
Fig. 11 illustrates a model of the -scorpion toxin
receptor site based on the LqTx and ATX II binding determinants
reported here, and two regions previously implicated in -scorpion
toxin binding (28, 20). In this model, -scorpion toxins are proposed
to bind across the IVS3-S4 loop through electrostatic interactions with
Glu1613 and additional, unidentified contacts in the IS5-S6
and IVS5-S6 loops. The voltage dependence of -scorpion toxin and
anemone toxin binding is due to steric interactions as the IVS4 segment
moves outward in response to depolarization and encounters bound toxin.
Torsion between the binding of -scorpion toxin to
Glu1613 and other determinants outside of the IVS3-S4 loop
results in an increased rate of toxin dissociation. The binding of sea
anemone toxins differs in that they bind intimately with several
residues of the IVS3-S4 loop through electrostatic, hydrogen-bonding,
or van der Waals interactions. Sea anemone toxin binding is less
voltage-dependent (18, 23), perhaps because it has fewer
binding contacts outside of the IVS3-S4 loop so is subjected to less
steric or torsional distortion when the channel is depolarized. Both of
these toxins may slow inactivation by slowing or preventing the
resulting conformational changes in the IVS3-S4 loop upon translocation
of the IVS4 segment.
Fig. 11.
A model for the -ScTx/ATX receptor.
A cross-sectional view of the Na+ channel depicting the
juxtaposition of domains I and IV on one side of the ion pore with
-ScTx or ATX bound. Also shown are the regions previously implicated
in -ScTx binding (lightly shaded segments), sites of glycosylation
( ), the intracellular III-IV loop which acts as the inactivation
gate (IFM) and contains a known site of phosphorylation
(P), and the IVS3-S4 loop closely interacting with bound
toxin (dark shaded segment). Outward movement of the IVS4 segment with
depolarization is inhibited by bound toxin and accelerates the off-rate
of bound toxin. Slowing of this translocation or of a subsequent
conformational change in the IVS3-S4 loop is proposed to slow the rate
of fast inactivation.
FOOTNOTES
*
This work was supported by Molecular and Cellular Biology
predoctoral training Grant T32-GM07270 and Department of Defense
predoctoral training contract supplement DAAH04-93-G-0096 (to J. C. R.), National Institutes of Health Research Grants P01 HL44948 and R01
NS15751 and Department of Defense Research Contract DAMD 17-90-C-0115
(to W. A. C.), and by a postdoctoral research fellowship from the
American Heart Association, Washington Affiliate (to Y. Q.). The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
1
The abbreviations used are: LqTx, toxin V
from Leiurus quinquestriatus; ATX II, Anemonia
sulcata toxin II; nt, nucleotides.
2
J. C. Rogers, Y. Qu, T. N. Tanada, T. Scheuer, and W. A. Catterall, unpublished observations.
REFERENCES
-
Hille, B.
(1992)
Ionic Channels of Excitable Membranes
, 2nd Ed.
, Sinauer
Associates, Sunderland, MA
-
Catterall, W. A.
(1980)
Annu. Rev. Pharmacol. Toxicol.
20,
15-43
[CrossRef][Medline]
[Order article via Infotrieve]
-
Catterall, W. A.
(1995)
Annu. Rev. Biochem.
64,
493-531
[CrossRef][Medline]
[Order article via Infotrieve]
-
Stühmer, W.,
Parekh, A. B.
(1992)
Curr. Opin. Neurobiol.
2,
243-246
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fontecilla-Camps, J. C.,
Almassy, R. J.,
Suddath, F. L.,
Bugg, C.
E.
(1982)
Toxicon
20,
1-7
-
Fontecilla-Camps, J. C.,
Habersetzer-Rochat, C.,
Rochat, H.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
7443-7447
[Abstract/Free Full Text]
-
Torda, A. E.,
Mabbutt, B. C.,
Van Grunsteren, W. F.,
Norton, R. S.
(1988)
FEBS Lett.
239,
266-270
[CrossRef][Medline]
[Order article via Infotrieve]
-
Widmer, H.,
Billeter, M.,
Wuthrich, K.
(1989)
Proteins
6,
357-371
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fogh, R. H.,
Kem, W. R.,
Norton, R. S.
(1990)
Biochemistry
28,
1826-1834
[CrossRef]
-
El Ayeb, M.,
Darbon, H.,
Bahraoui, E. M.,
Vargas, O.,
Rochat, H.
(1986)
Eur. J. Biochem.
155,
289-294
[Medline]
[Order article via Infotrieve]
-
Kharrat, R.,
Darbon, H.,
Rochat, H.,
Granier, C.
(1989)
Eur. J. Biochem.
181,
381-390
[Medline]
[Order article via Infotrieve]
-
Kharrat, R.,
Darbon, H.,
Granier, C.,
Rochat, H.
(1990)
Toxicon
28,
509-523
[Medline]
[Order article via Infotrieve]
-
Barhanin, J.,
Hugues, M.,
Schweitz, H.,
Vincent, J.-P.,
Lazdunski, M.
(1981)
J. Biol. Chem.
256,
5764-5769
[Abstract/Free Full Text]
-
Lorett, E. P.,
Soto,
Valle, R. M.,
Mansuelle, P.,
Sampieri, F.,
Rochat, H.
(1994)
J. Biol. Chem.
269,
16785-16788
[Abstract/Free Full Text]
-
Gallagher, M. J.,
Blumenthal, K. M.
(1994)
J. Biol. Chem.
269,
254-259
[Abstract/Free Full Text]
-
Khera, P. K.,
Benzinger, G. R.,
Blumenthal, K. M.
(1995)
Biochemistry
34,
8533-8541
[CrossRef][Medline]
[Order article via Infotrieve]
-
Catterall, W. A.
(1977)
J. Biol. Chem.
252,
8660-8668
[Free Full Text]
-
Catterall, W. A.,
Beress, L.
(1978)
J. Biol. Chem.
253,
7393-7396
[Abstract/Free Full Text]
-
Catterall, W. A.
(1979)
J. Gen. Physiol.
74,
375-391
[Abstract/Free Full Text]
-
Mozhayeva, G. N.,
Naumov, A. P.,
Nosyreva, E. D.,
Grishin, E. V.
(1980)
Biochim Biophys Acta
597,
587-602
[Medline]
[Order article via Infotrieve]
-
Meves, H.,
Rubly, N.,
Watt, D. D.
(1984)
Pfluegers Arch.
402,
24-33
[CrossRef][Medline]
[Order article via Infotrieve]
-
Strichartz, G. R.,
Wang, G. K.
(1986)
J. Gen. Physiol.
88,
413-435
[Abstract/Free Full Text]
-
Wang, G. K.,
Strichartz, G.
(1985)
J. Gen. Physiol.
86,
739-762
[Abstract/Free Full Text]
-
Beneski, D. A.,
Catterall, W. A.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
639-643
[Abstract/Free Full Text]
-
Darbon, H.,
Jover, E.,
Rochat, H.
(1983)
Biochem. Biophys. Res. Commun.
115,
415-422
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sharkey, R. G.,
Beneski, D. A.,
Catterall, W. A.
(1984)
Biochemistry
23,
6078-6086
[CrossRef][Medline]
[Order article via Infotrieve]
-
West, J. W.,
Scheuer, T.,
Maechler, L.,
Catterall, W. A.
(1992)
Neuron
8,
59-70
[CrossRef][Medline]
[Order article via Infotrieve]
-
Tejedor, F. J.,
Catterall, W. A.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8742-8746
[Abstract/Free Full Text]
-
Thomsen, W. J.,
Catterall, W. A.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
10161-10165
[Abstract/Free Full Text]
-
Noda, M.,
Ikeda, T.,
Kayano, T.,
Suzuki, H.,
Takeshima, H.,
Kurasaki, M.,
Takahashi, H.,
Numa, S.
(1986)
Nature
320,
188-192
[CrossRef][Medline]
[Order article via Infotrieve]
-
Auld, V. J.,
Goldin, A. L.,
Krafte, D. S.,
Marshall, J.,
Dunn, J.,
Catterall, W. A.,
Lester, H. A.,
Davidson, N.,
Dunn, R. J.
(1988)
Neuron
1,
449-461
[CrossRef][Medline]
[Order article via Infotrieve]
-
Auld, V. J.,
Goldin, A. L.,
Krafte, D. S.,
Catterall, W. A.,
Lester, H.
A.,
Davidson, N.,
Dunn, R. J.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
323-327
[Abstract/Free Full Text]
-
Kunkel, T. A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492
[Abstract/Free Full Text]
-
Rogart, R. B.,
Cribbs, L. L.,
Muglia, L. K.,
Kephart, D. D.,
Kaiser, M. W.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
8170-8174
[Abstract/Free Full Text]
-
Margolskee, R. F.,
McHendry-Rinde, B.,
Horn, R.
(1993)
BioTechniques
15,
906-911
[Medline]
[Order article via Infotrieve]
-
Jurman, M. E.,
Boland, L. M.,
Yellen, G.
(1994)
BioTechniques
17,
876-881
[Medline]
[Order article via Infotrieve]
-
Peterson, G. L.
(1983)
Methods Enzymol.
91,
95-119
[Medline]
[Order article via Infotrieve]
-
Isom, L. L.,
Scheuer, T.,
Brownstein, A. B.,
Ragsdale, D. S.,
Murphy, B. J.,
Catterall, W. A.
(1995)
J. Biol. Chem.
270,
3306-3312
[Abstract/Free Full Text]
-
Qu, Y.,
Rogers, J. C.,
Tanada, T.,
Scheuer, T.,
Catterall, W. A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3289-3293
[Abstract/Free Full Text]
-
Levitt, D. G.,
Decker, E. R.
(1988)
Biophys. J.
53,
33-38
[Medline]
[Order article via Infotrieve]
-
Nagy, K.
(1988)
J. Membr. Biol.
106,
29-40
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mozhayeva, G. N.,
Naumov, A. P.,
Kuryshev, Y. A.,
Nosyreva, E. D.
(1990)
Gen. Physiol. Biophys.
9,
3-18
[Medline]
[Order article via Infotrieve]
-
Greenblatt, R. E.,
Blatt, Y.,
Montal, Y.
(1985)
FEBS Lett.
193,
125-134
[CrossRef][Medline]
[Order article via Infotrieve]
-
Guy, H. R.,
Seetharamulu, P.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
508-512
[Abstract/Free Full Text]
-
Predict-Protein{at}EMBL-Heidelberg.de (1995)http://www.public.iastate.edu/mfpedro/pprotein_query.html
-
Catterall, W. A.,
Coppersmith, J.
(1981)
Mol. Pharmacol.
20,
533-542
[Abstract/Free Full Text]
-
Gonoi, T.,
Hille, B.,
Catterall, W. A.
(1984)
J. Neurosci.
4,
2836-2842
[Abstract]
-
Monod, J.,
Wyman, J.,
Changeux, J.-P.
(1965)
J. Mol. Biol.
12,
88-118
[Medline]
[Order article via Infotrieve]
-
Jover, E.,
Martin-Moutot, N.,
Couraud, F.,
Rochat, H.
(1978)
Biochem. Biophys. Res. Commun.
85,
377-382
[CrossRef][Medline]
[Order article via Infotrieve]
-
Armstrong, C. M.,
Bezanilla, F.
(1977)
J. Gen. Physiol.
70,
567-590
[Abstract/Free Full Text]
-
Mozhayeva, G. N.,
Naumov, A. P.
(1981)
Neurophysiology
12,
409-415
-
Nonner, W.
(1979)
Adv. Cytopharmacol.
3,
345-352
[Medline]
[Order article via Infotrieve]
-
Neumcke, B.,
Schwarz, W.,
Stampfi, R.
(1985)
Biochim. Biophys. Acta
814,
111-119
[Medline]
[Order article via Infotrieve]
-
Yang, N.,
Horn, R.
(1995)
Neuron
15,
213-218
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ptacek, L. J.,
Gouw, L.,
Kwiecinski, H.,
McManis, P.,
Mendell, J. R.,
Barohn, R. J.,
George, A. L., Jr.,
Barchi, R. L.,
Robertson, M.,
Leppert, M. F.
(1993)
Ann. Neurol.
33,
300-307
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Xiao, J.-P. Bingham, W. Zhu, E. Moczydlowski, S. Liang, and T. R. Cummins
Tarantula Huwentoxin-IV Inhibits Neuronal Sodium Channels by Binding to Receptor Site 4 and Trapping the Domain II Voltage Sensor in the Closed Configuration
J. Biol. Chem.,
October 3, 2008;
283(40):
27300 - 27313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. V. Campos, B. Chanda, P. S.L. Beirao, and F. Bezanilla
{alpha}-Scorpion Toxin Impairs a Conformational Change that Leads to Fast Inactivation of Muscle Sodium Channels
J. Gen. Physiol.,
July 28, 2008;
132(2):
251 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sokolov, R. L. Kraus, T. Scheuer, and W. A. Catterall
Inhibition of Sodium Channel Gating by Trapping the Domain II Voltage Sensor with Protoxin II
Mol. Pharmacol.,
March 1, 2008;
73(3):
1020 - 1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Surber, S. Hensellek, D. Prochnau, G. S. Werner, K. Benndorf, H. R. Figulla, and T. Zimmer
Combination of cardiac conduction disease and long QT syndrome caused by mutation T1620K in the cardiac sodium channel
Cardiovasc Res,
March 1, 2008;
77(4):
740 - 748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Milescu, J. Vobecky, S. H. Roh, S. H. Kim, H. J. Jung, J. I. Kim, and K. J. Swartz
Tarantula Toxins Interact with Voltage Sensors within Lipid Membranes
J. Gen. Physiol.,
October 29, 2007;
130(5):
497 - 511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Smith, T. R. Cummins, S. Alphy, and K. M. Blumenthal
Molecular Interactions of the Gating Modifier Toxin ProTx-II with Nav1.5: IMPLIED EXISTENCE OF A NOVEL TOXIN BINDING SITE COUPLED TO ACTIVATION
J. Biol. Chem.,
April 27, 2007;
282(17):
12687 - 12697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Corzo, J. K. Sabo, F. Bosmans, B. Billen, E. Villegas, J. Tytgat, and R. S. Norton
Solution Structure and Alanine Scan of a Spider Toxin That Affects the Activation of Mammalian Voltage-gated Sodium Channels
J. Biol. Chem.,
February 16, 2007;
282(7):
4643 - 4652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Armstrong
Na channel inactivation from open and closed states
PNAS,
November 21, 2006;
103(47):
17991 - 17996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cohen, N. Lipstein, and D. Gordon
Allosteric interactions between scorpion toxin receptor sites on voltage-gated Na channels imply a novel role for weakly active components in arthropod venom
FASEB J,
September 1, 2006;
20(11):
1933 - 1935.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cestele, V. Yarov-Yarovoy, Y. Qu, F. Sampieri, T. Scheuer, and W. A. Catterall
Structure and Function of the Voltage Sensor of Sodium Channels Probed by a beta-Scorpion Toxin
J. Biol. Chem.,
July 28, 2006;
281(30):
21332 - 21344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cohen, N. Gilles, I. Karbat, N. Ilan, D. Gordon, and M. Gurevitz
Direct Evidence That Receptor Site-4 of Sodium Channel Gating Modifiers Is Not Dipped in the Phospholipid Bilayer of Neuronal Membranes
J. Biol. Chem.,
July 28, 2006;
281(30):
20673 - 20679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Schiavon, T. Sacco, R. R. Cassulini, G. Gurrola, F. Tempia, L. D. Possani, and E. Wanke
Resurgent Current and Voltage Sensor Trapping Enhanced Activation by a beta-Scorpion Toxin Solely in Nav1.6 Channel: SIGNIFICANCE IN MICE PURKINJE NEURONS
J. Biol. Chem.,
July 21, 2006;
281(29):
20326 - 20337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Maertens, E. Cuypers, M. Amininasab, A. Jalali, H. Vatanpour, and J. Tytgat
Potent Modulation of the Voltage-Gated Sodium Channel Nav1.7 by OD1, a Toxin from the Scorpion Odonthobuthus doriae
Mol. Pharmacol.,
July 1, 2006;
70(1):
405 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-W. Kang, J.-Y. Park, S.-W. Jeong, J.-A. Kim, H.-J. Moon, E. Perez-Reyes, and J.-H. Lee
A Molecular Determinant of Nickel Inhibition in Cav3.2 T-type Calcium Channels
J. Biol. Chem.,
February 24, 2006;
281(8):
4823 - 4830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. West, G. Bulaj, and D. Yoshikami
Effects of {delta}-Conotoxins PVIA and SVIE on Sodium Channels in the Amphibian Sympathetic Nervous System
J Neurophysiol,
December 1, 2005;
94(6):
3916 - 3924.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Ulbricht
Sodium Channel Inactivation: Molecular Determinants and Modulation
Physiol Rev,
October 1, 2005;
85(4):
1271 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xiao, J. Tang, W. Hu, J. Xie, C. Maertens, J. Tytgat, and S. Liang
Jingzhaotoxin-I, a Novel Spider Neurotoxin Preferentially Inhibiting Cardiac Sodium Channel Inactivation
J. Biol. Chem.,
April 1, 2005;
280(13):
12069 - 12076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Smith, S. Alphy, A. L. Seibert, and K. M. Blumenthal
Differential Phospholipid Binding by Site 3 and Site 4 Toxins: IMPLICATIONS FOR STRUCTURAL VARIABILITY BETWEEN VOLTAGE-SENSITIVE SODIUM CHANNEL DOMAINS
J. Biol. Chem.,
March 25, 2005;
280(12):
11127 - 11133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sunami, A. Tracey, I. W Glaaser, G. M Lipkind, D. A Hanck, and H. A Fozzard
Accessibility of mid-segment domain IV S6 residues of the voltage-gated Na+ channel to methanethiosulfonate reagents
J. Physiol.,
December 1, 2004;
561(2):
403 - 413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Oliveira, E. Redaelli, A. J. Zaharenko, R. R. Cassulini, K. Konno, D. C. Pimenta, J. C. Freitas, J. J. Clare, and E. Wanke
Binding Specificity of Sea Anemone Toxins to Nav 1.1-1.6 Sodium Channels: UNEXPECTED CONTRIBUTIONS FROM DIFFERENCES IN THE IV/S3-S4 OUTER LOOP
J. Biol. Chem.,
August 6, 2004;
279(32):
33323 - 33335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Karbat, F. Frolow, O. Froy, N. Gilles, L. Cohen, M. Turkov, D. Gordon, and M. Gurevitz
Molecular Basis of the High Insecticidal Potency of Scorpion {alpha}-Toxins
J. Biol. Chem.,
July 23, 2004;
279(30):
31679 - 31686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Wang, S. H. Roh, S. Kim, C. W. Lee, J. I. Kim, and K. J. Swartz
Molecular Surface of Tarantula Toxins Interacting with Voltage Sensors in Kv Channels
J. Gen. Physiol.,
March 29, 2004;
123(4):
455 - 467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Leipold, S. Lu, D. Gordon, A. Hansel, and S. H. Heinemann
Combinatorial Interaction of Scorpion Toxins Lqh-2, Lqh-3, and Lqh{alpha}IT with Sodium Channel Receptor Sites-3
Mol. Pharmacol.,
March 1, 2004;
65(3):
685 - 691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vais, S. Atkinson, F. Pluteanu, S. J. Goodson, A. L. Devonshire, M. S. Williamson, and P. N. R. Usherwood
Mutations of the para Sodium Channel of Drosophila melanogaster Identify Putative Binding Sites for Pyrethroids
Mol. Pharmacol.,
October 1, 2003;
64(4):
914 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Salceda, A. Garateix, and E. Soto
The Sea Anemone Toxins BgII and BgIII Prolong the Inactivation Time Course of the Tetrodotoxin-Sensitive Sodium Current in Rat Dorsal Root Ganglion Neurons
J. Pharmacol. Exp. Ther.,
December 1, 2002;
303(3):
1067 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Peng, Q. Shu, Z. Liu, and S. Liang
Function and Solution Structure of Huwentoxin-IV, a Potent Neuronal Tetrodotoxin (TTX)-sensitive Sodium Channel Antagonist from Chinese Bird Spider Selenocosmia huwena
J. Biol. Chem.,
November 27, 2002;
277(49):
47564 - 47571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Chanda and F. Bezanilla
Tracking Voltage-dependent Conformational Changes in Skeletal Muscle Sodium Channel during Activation
J. Gen. Physiol.,
October 29, 2002;
120(5):
629 - 645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Yarov-Yarovoy, J. C. McPhee, D. Idsvoog, C. Pate, T. Scheuer, and W. A. Catterall
Role of Amino Acid Residues in Transmembrane Segments IS6 and IIS6 of the Na+ Channel alpha Subunit in Voltage-dependent Gating and Drug Block
J. Biol. Chem.,
September 13, 2002;
277(38):
35393 - 35401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kajiwara, T. Yanagita, Y. Nakashima, A. Wada, F. Izumi, and N. Yanagihara
Differential Effects of Short and Prolonged Exposure to Carvedilol on Voltage-Dependent Na+ Channels in Cultured Bovine Adrenal Medullary Cells
J. Pharmacol. Exp. Ther.,
July 1, 2002;
302(1):
212 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Shichor, E. Zlotkin, N. Ilan, D. Chikashvili, W. Stuhmer, D. Gordon, and I. Lotan
Domain 2 of Drosophila Para Voltage-Gated Sodium Channel Confers Insect Properties to a Rat Brain Channel
J. Neurosci.,
June 1, 2002;
22(11):
4364 - 4371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Alessandri-Haber, G. Alcaraz, C. Deleuze, F. Jullien, C. Manrique, F. Couraud, M. Crest, and P. Giraud
Molecular determinants of emerging excitability in rat embryonic motoneurons
J. Physiol.,
May 15, 2002;
541(1):
25 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Sidach and I. M. Mintz
Kurtoxin, A Gating Modifier of Neuronal High- and Low-Threshold Ca Channels
J. Neurosci.,
March 15, 2002;
22(6):
2023 - 2034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Li, I. L. Ennis, G. F. Tomaselli, and E. Marban
Structural Basis of Differences in Isoform-Specific Gating and Lidocaine Block between Cardiac and Skeletal Muscle Sodium Channels
Mol. Pharmacol.,
January 1, 2002;
61(1):
136 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mantegazza, F. H. Yu, W. A. Catterall, and T. Scheuer
Role of the C-terminal domain in inactivation of brain and cardiac sodium channels
PNAS,
December 6, 2001;
(2001)
211563298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Johnson Jr, J. R. Balser, and P. B. Bennett
A Novel Extracellular Calcium Sensing Mechanism in Voltage-Gated Potassium Ion Channels
J. Neurosci.,
June 15, 2001;
21(12):
4143 - 4153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kinoshita, H. Maejima, K. Yamaoka, K. Konno, N. Kawai, E. Shimizu, S. Yokote, H. Nakayama, and I. Seyama
Novel Wasp Toxin Discriminates between Neuronal and Cardiac Sodium Channels
Mol. Pharmacol.,
June 1, 2001;
59(6):
1457 - 1463.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Shiraishi, T. Yanagita, H. Kobayashi, Y. Uezono, H. Yokoo, S.-I. Minami, M. Takasaki, and A. Wada
Up-Regulation of Cell Surface Sodium Channels by Cyclosporin A, FK506, and Rapamycin in Adrenal Chromaffin Cells
J. Pharmacol. Exp. Ther.,
April 12, 2001;
297(2):
657 - 665.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Zhong, B. Li, T. Scheuer, and W. A. Catterall
Control of gating mode by a single amino acid residue in transmembrane segment IS3 of the N-type Ca2+ channel
PNAS,
April 10, 2001;
98(8):
4705 - 4709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Wright
Irreversible Block of Human Heart (hH1) Sodium Channels by the Plant Alkaloid Lappaconitine
Mol. Pharmacol.,
February 1, 2001;
59(2):
183 - 192.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F Grolleau, M Stankiewicz, L Birinyi-Strachan, X. Wang, G. Nicholson, M Pelhate, and B Lapied
Electrophysiological analysis of the neurotoxic action of a funnel-web spider toxin, delta-atracotoxin-HV1a, on insect voltage-gated Na+ channels
J. Exp. Biol.,
January 2, 2001;
204(4):
711 - 721.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lee, M. Gurevitz, and M. E. Adams
Modification of Synaptic Transmission and Sodium Channel Inactivation by the Insect-Selective Scorpion Toxin Lqhalpha IT
J Neurophysiol,
March 1, 2000;
83(3):
1181 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Madeja
Extracellular Surface Charges in Voltage-Gated Ion Channels
Physiology,
February 1, 2000;
15(1):
15 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Makita, N. Shirai, D. W. Wang, K. Sasaki, A. L. George Jr, M. Kanno, and A. Kitabatake
Cardiac Na+ Channel Dysfunction in Brugada Syndrome Is Aggravated by {beta}1-Subunit
Circulation,
January 4, 2000;
101(1):
54 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. McCormick, J. Srinivasan, K. White, T. Scheuer, and W. A. Catterall
The Extracellular Domain of the beta 1 Subunit Is Both Necessary and Sufficient for beta 1-like Modulation of Sodium Channel Gating
J. Biol. Chem.,
November 12, 1999;
274(46):
32638 - 32646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Qu, J. C. Rogers, S.-F. Chen, K. A. McCormick, T. Scheuer, and W. A. Catterall
Functional Roles of the Extracellular Segments of the Sodium Channel alpha Subunit in Voltage-dependent Gating and Modulation by beta 1 Subunits
J. Biol. Chem.,
November 12, 1999;
274(46):
32647 - 32654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gilles, C. Blanchet, I. Shichor, M. Zaninetti, I. Lotan, D. Bertrand, and D. Gordon
A Scorpion alpha -Like Toxin That Is Active on Insects and Mammals Reveals an Unexpected Specificity and Distribution of Sodium Channel Subtypes in Rat Brain Neurons
J. Neurosci.,
October 15, 1999;
19(20):
8730 - 8739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lehmann-Horn and K. Jurkat-Rott
Voltage-Gated Ion Channels and Hereditary Disease
Physiol Rev,
October 1, 1999;
79(4):
1317 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Lin, Y. Lin, S. Schorge, J. Q. Pan, M. Beierlein, and D. Lipscombe
Alternative Splicing of a Short Cassette Exon in alpha 1B Generates Functionally Distinct N-Type Calcium Channels in Central and Peripheral Neurons
J. Neurosci.,
July 1, 1999;
19(13):
5322 - 5331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Balser
Structure and function of the cardiac sodium channels
Cardiovasc Res,
May 1, 1999;
42(2):
327 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Linford, A. R. Cantrell, Y. Qu, T. Scheuer, and W. A. Catterall
Interaction of batrachotoxin with the local anesthetic receptor site in transmembrane segment IVS6 of the voltage-gated sodium channel
PNAS,
November 10, 1998;
95(23):
13947 - 13952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Little, C. Zappia, N. Gilles, M. Connor, M. I. Tyler, M.-F. Martin-Eauclaire, D. Gordon, and G. M. Nicholson
delta -Atracotoxins from Australian Funnel-web Spiders Compete with Scorpion alpha -Toxin Binding but Differentially Modulate Alkaloid Toxin Activation of Voltage-gated Sodium Channels
J. Biol. Chem.,
October 16, 1998;
273(42):
27076 - 27083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li-Smerin and K. J. Swartz
Gating modifier toxins reveal a conserved structural motif in voltage-gated Ca2+ and K+ channels
PNAS,
July 21, 1998;
95(15):
8585 - 8589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marban, T. Yamagishi, and G. F Tomaselli
Structure and function of voltage-gated sodium channels
J. Physiol.,
May 1, 1998;
508(3):
647 - 657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mantegazza, S. Franceschetti, and G. Avanzini
Anemone toxin (ATX II)-induced increase in persistent sodium current: effects on the firing properties of rat neocortical pyramidal neurones
J. Physiol.,
February 15, 1998;
507(1):
105 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. McPhee, D. S. Ragsdale, T. Scheuer, and W. A. Catterall
A Critical Role for the S4-S5 Intracellular Loop in Domain IV of the Sodium Channel alpha -Subunit in Fast Inactivation
J. Biol. Chem.,
January 9, 1998;
273(2):
1121 - 1129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Benzinger, J. W. Kyle, K. M. Blumenthal, and D. A. Hanck
A Specific Interaction between the Cardiac Sodium Channel and Site-3 Toxin Anthopleurin B
J. Biol. Chem.,
January 2, 1998;
273(1):
80 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. McDonough, R. A. Lampe, R. A. Keith, and B. P. Bean
Voltage-Dependent Inhibition of N- and P-Type Calcium Channels by the Peptide Toxin omega -Grammotoxin-SIA
Mol. Pharmacol.,
December 1, 1997;
52(6):
1095 - 1104.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Kellenberger, T. Scheuer, and W. A. Catterall
Movement of the Na+ Channel Inactivation Gate during Inactivation
J. Biol. Chem.,
November 29, 1996;
271(48):
30971 - 30979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Liu, D. P. Schachtman, and W. Zhang
Partial Deletion of a Loop Region in the High Affinity K+ Transporter HKT1 Changes Ionic Permeability Leading to Increased Salt Tolerance
J. Biol. Chem.,
September 1, 2000;
275(36):
27924 - 27932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mantegazza, F. H. Yu, W. A. Catterall, and T. Scheuer
Role of the C-terminal domain in inactivation of brain and cardiac sodium channels
PNAS,
December 18, 2001;
98(26):
15348 - 15353.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|